Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03965650
Other study ID # APHP190622
Secondary ID 2019-A01384-53
Status Recruiting
Phase N/A
First received
Last updated
Start date February 24, 2022
Est. completion date February 2024

Study information

Verified date February 2023
Source Assistance Publique - Hôpitaux de Paris
Contact Patrick Le Goux, MD
Phone + 33 1 49 09 56 84
Email patrick.legoux@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of the study is to demonstrate the beneficial effect of a 3 months home-based physical exercise program supervised by online videos, in addition to the usual recommendations, in comparison with usual physical activity as recommended by the WHO. The secondary objectives of the study are : 1. to compare the following criteria between 2 groups at 3 and 6 months: - quality of life; - other measures of disease activity ; - sleep quality ; - walking ability - muscle strength of; - professional activity; - cost of cares; - evolution of weight, BMI and waist. 2. to evaluate the observance of physical activity program and its tolerance at 3 and 6 months.


Description:

The spondyloarthritides are a group of inflammatory rheumatic diseases, including ankylosing spondylitis, reactive arthritis, inflammatory bowel disease-related rheumatic disease, and psoriatic arthritis. The frequence of axial spondyloarthritis is 0.41% in the french population. This disease is associated with a reduction of physical capacities and quality of life. NSAIDs or even biologic therapies do not always permit a sufficient control of the disease. Different physical exercise programs can be effective as an additional therapy for spondyloarthritis, with positive effects on spinal mobility as well as main disease activity and functional indices (BASDAI, BASFI and BASMI). The severity of the disease does not seem to influence significantly the patients' motivation in practicing physical activity. This proposed study aims to demonstrate the beneficial effect of physical exercises coached with a specific internet program diffused on a secured platform. Each patient will have to connect 3 times weekly in order to follow the entire program. The impact will be evaluated at 3 months and 6 months. Potential impacts of video-coaching program are: - reduction of the intrinsic inflammatory activity of the rheumatic disease; - improvement of the global physical condition: muscular strength and resistance, walking ability, chest expansion; - reduction of fatigue and improvement of sleeping; - reduction of consumption of symptomatic drug (analgesics, NSAIDs, corticosteroids).


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date February 2024
Est. primary completion date February 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patient between 18 and 65 years; - Patient can read and understand French; - Signed informed consent form to participate in the study; - Axial spondylarthritis according to ASAS criteria; - Patient with a BASDAI score between 2.5 and 5; - No change of biotherapy anti-TNF or anti-IL17 during the 3 months preceding the inclusion; - Patient equipped with an internet access; - Medical certificate of proposed physical activities. Exclusion Criteria: - All diseases (cardiovascular disease or chronic neurological disease or others) contraindicating the requested exercises according to physician; - Axial spondyloarthritis in remission defined by a BASDAI < 2.5/10 or in excessive inflammatory activity, defined by BASDAI > 5/10; - Pregnant woman (positive pregnant test) or woman try to conceive in following 6 months; - Patient with articular prosthesis; - Patient who already participate in a specific exercise program or practice a sport (including Yoga or Tai Chi) more than one hour per week; - Severe obesity ( BMI > 35); - Patient without health insurance; - Patient legally unable.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Video coaching exercises
Patients will perform physical exercises following a specifical video coaching program during 6 months.
Routine exercises
Routine method by advising and encouraging patients to perform exercises according to the WHO recommendations during the first 3 months of the study. Thereafter, patients will have access to the video coaching program of physical activities during the following 3 months.

Locations

Country Name City State
France Service de rhumatologie, Hôpital Ambroise Paré Boulogne-Billancourt Hauts-de-Seine

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients responding to the "ASAS 20" criterion at 3 months The primary outcome measure will be the proportion of patients simultaneously satisfying both criteria :
at least 20% improvement
improvement of at least 10 points on visual analog scale in the following domains: overall evaluation by the patient, visual analog scale (pain scale), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
at 3 months
Secondary Ankylosing Spondylitis Disease Activity : (BASDAI) (PRO) Ankylosing Spondylitis Disease Activity will be assessed with the Bath Ankylosing Spondylitis Disease Activity (BASDAI) auto-questionnaire assessing the inflammatory activity of the disease. at baseline, 3 months and 6 months
Secondary Ankylosing Spondylitis Disease Activity : (ASDAS CRP) (PRO) Ankylosing Spondylitis Disease Activity will be assessed with the Ankylosing Spondylitis Disease Activity Score (ASDAS CRP) auto-questionnaire assessing the inflammatory activity of the disease. at baseline, 3 months and 6 months
Secondary Bath Ankylosing Spondylitis Functional Index (BASFI) (PRO) Data collected with the Bath Ankylosing Spondylitis Functional Index (BASFI) auto-questionnaire assessing the functional impact of disease. at baseline, 3 months and 6 months
Secondary Fatigue (PRO) Fatigue will be assessed with a Visual Analogue Scale at baseline, 3 months and 6 months
Secondary Health assessment: HAQ-S (PRO) SpA-related health will be assessed with the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S) at baseline, 3 months and 6 months
Secondary SPA impact on general health: ASAS-HI (PRO) General health will be assessed with the ASAS Health Index auto-questionnaire at baseline, 3 months and 6 months
Secondary Work Productivity and Activity : WPAI (PRO) Work Productivity and Activity will be assessed with the Work Productivity and Activity Impairment (WPAI) auto-questionnaire at baseline, 3 months and 6 months
Secondary Sleep quality: PSQI Sleep quality will be assessed with the Pittsburgh Sleep Quality Index (PSQI) auto-questionnaire at baseline, 3 months and 6 months
Secondary Physical activity: IPAQ (PRO) Physical activity will be assessed with the International Physical Activity Questionnaire (IPAQ) - Short Form and Long Form auto-questionnaires at baseline, 3 months and 6 months
Secondary Analgesic and anti-inflammatory drug intake Following drugs intake will be collected:
non-steroidal anti-inflammatory drugs (NSAIDs)
corticosteroids
at 3 months and 6 months
Secondary Anthropometric measures: BASMI The functional impact of SpA will be assessed with the Bath Ankylosing Spondylitis Metrology Index (BASMI) at baseline, 3 months and 6 months
Secondary Anthropometric measures: Enthesitis: MASES Entesis involvement will be assessed with the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) at baseline, 3 months and 6 months
Secondary Anthropometric measures: Muscle strength: dynamometer Muscle strength of the upper and lower limbs will be assessed with a dynamometer at baseline, 3 months and 6 months
Secondary Anthropometric measures: 6-minutes walk test Walking ability will be assessed with the 6-minutes walking test. at baseline, 3 months and 6 months
Secondary Anthropometric measures: Body mass index (BMI) Weight, height and waist size will be collected to calculate the BMI of patients. at baseline, 3 months and 6 months
See also
  Status Clinical Trial Phase
Completed NCT05031767 - Remote Monitoring of Axial Spondyloarthritis N/A
Completed NCT05162937 - to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis Phase 2
Completed NCT03622658 - Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis Phase 2
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Terminated NCT02437162 - A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis Phase 3
Enrolling by invitation NCT06072859 - The Impact of Simulated Forest Immersion Therapy on Pain and Anxiety in Patients Axial Spondyloarthritis (axSpA) N/A
Completed NCT02552212 - Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS Phase 3
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Active, not recruiting NCT02687620 - Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Completed NCT00844805 - Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Phase 3
Terminated NCT02897115 - A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment Phase 4
Completed NCT05019547 - The Turkish Version of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity
Recruiting NCT03738956 - Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial Phase 2/Phase 3
Enrolling by invitation NCT02962479 - Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis? N/A
Completed NCT04485078 - Investigation of Central Sensitization Frequency and Related Factors in Axial Spondyloarthritis Patients
Recruiting NCT05812157 - Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17 N/A
Completed NCT03039088 - PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients
Completed NCT04368494 - Exercise Therapy in Patients With Axial Spondyloarthritis N/A
Completed NCT03270501 - Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation Phase 3
Completed NCT03043846 - Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)